Skip to content

Clinical trials

Terminated Inflammatory Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Status: Terminated Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20051
20061
20081
20142
20151
20161
20172
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center7
BerGenBio ASA1
Duke University1
European Organisation for Research and Treatment of Cancer - EORTC1
Jules Bordet Institute1
National Cancer Institute (NCI)1
Northwestern University1
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University1
University Health Network, Toronto1
University of Medicine and Dentistry of New Jersey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms17
Breast Neoplasms15
Triple Negative Breast Neoplasms2
Breast Carcinoma In Situ1
Breast Neoplasms, Male1
Cardiotoxicity1
Head and Neck Neoplasms1
Hypopharyngeal Neoplasms1
Laryngeal Neoplasms1
Mouth Neoplasms1

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.